D16-M1P2

N/A

Report date: 2025/12/26 14:28:44
NME

Base Information

Drug NameD16-M1P2
Drug Alias NameD16-M1P2
ClassificationSmall molecules > Proteolysis-Targeting Chimera (PROTAC)
Mechanisms of ActionMembrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase inhibitorsMembrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase degraders
TargetsMembrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInsilico Medicine Ltd
China Registration ClassN/A

Develop Information

Active CompaniesInsilico Medicine Ltd
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A